ARROW PHARMACEUTICALS

Serial Number 78605127
604

Registration Progress

Application Filed
Apr 8, 2005
Under Examination
Approved for Publication
Aug 9, 2006
Published for Opposition
Aug 29, 2006
Registered

Trademark Image

ARROW PHARMACEUTICALS

Basic Information

Serial Number
78605127
Filing Date
April 8, 2005
Published for Opposition
August 29, 2006
Abandonment Date
January 31, 2007
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
604
Status Date
Jan 31, 2007

Rights Holder

Arrow Pharmaceuticals Inc.

03
Address
6500 Kitimat Road
Mississauga, Ontario L5N 2B8
CA

Ownership History

Arrow Pharmaceuticals Inc.

Original Applicant
03
Mississauga, Ontario CA

Arrow Pharmaceuticals Inc.

Owner at Publication
03
Mississauga, Ontario CA

Legal Representation

Attorney
Sally M. Abel, Esq.

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Jan 31, 2007 OP.D T OPPOSITION DISMISSED NO. 999999 Loading...
Jan 31, 2007 ABN4 O ABANDONMENT - AFTER INTER PARTES DECISION Loading...
Jan 31, 2007 MAB4 O ABANDONMENT NOTICE MAILED - INTER PARTES DECISION Loading...
Oct 24, 2006 OP.I T OPPOSITION INSTITUTED NO. 999999 Loading...
Sep 28, 2006 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Aug 29, 2006 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 9, 2006 NPUB O NOTICE OF PUBLICATION Loading...
Jul 3, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 30, 2006 ALIE A ASSIGNED TO LIE Loading...
Jun 24, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 17, 2005 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 17, 2005 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 5, 2005 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 22, 2005 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 15, 2005 NWAP I NEW APPLICATION ENTERED Loading...

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
PHARMACEUTICALS